Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Technologies Inks Licensing Deal with RIKEN

NEW YORK, Nov. 13 – Third Wave Technologies has licensed over 3,300 genetic markers from Japan’s Institute of Physical and Chemical Research, the organizations announced Tuesday.

The agreement gives Third Wave Technologies, based in Madison, Wis., the worldwide license, excluding Japan, to research and clinical diagnostic applications to patents for genetic markers within approximately 200 genes related to drug metabolism regulation, according to the company.

Financial details of the agreement were not disclosed, though a Third Wave spokesperson told GenomeWeb that the deal included an upfront payment and royalties, and that Third Wave would hold the license as long as the Institute of Physical and Chemical Research, or RIKEN, holds the patents to the markers.

The markers were discovered as part of the of the Japanese government’s SNP Initiative, according to Third Wave. Third Wave plans to use the markers in a series of its Invader genetic variation analysis products for research and clinical diagnostic applications. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.